ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
170 hedge funds and large institutions have $1.51B invested in Acorda Therapeutics in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 65 increasing their positions, 61 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
63% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 32
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
170
Holding in Top 10
–
Calls
$2.5M
Puts
$2.5M
Top Buyers
| 1 | +$28.1M | |
| 2 | +$11.7M | |
| 3 | +$6.98M | |
| 4 |
AC
Armistice Capital
New York
|
+$6.2M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$14.5M | |
| 3 | -$8.32M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$7.63M |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$6.59M |